FdaNdcDirectoryPulse / compare

BRYTLY vs BYT BANGYTONG STYE EYE RELIEF SERUM: FdaNdcDirectoryPulse comparison

BRYTLY (2026-10-16) and BYT BANGYTONG STYE EYE RELIEF SERUM (2026-10-22) are peer FdaNdcDirectoryPulse records.

Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA

Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does BRYTLY compare to BYT BANGYTONG STYE EYE RELIEF SERUM?

FieldBRYTLYBYT BANGYTONG STYE EYE RELIEF SERUM
ProductBRYTLYBYT BANGYTONG STYE EYE RELIEF SERUM
Generic nameApraclonidine Hydrochloride(hippophae rhamnoides seed oil , calendula officinalis flower , persea gratissima- avocado oil liquid)
NDC0065-859687382-028
LabelerAlcon Laboratories, Inc.Shenzhen Jindali Technology Co., Ltd
Product typeHUMAN OTC DRUGHUMAN OTC DRUG
Approval pathwayNDAOTC MONOGRAPH DRUG
Application numberNDA220341505G(a)(3)
Dosage formSOLUTION/ DROPSLIQUID
RouteOPHTHALMICTOPICAL
Active ingredientsAPRACLONIDINE HYDROCHLORIDE 1.25 mg/mLPERSEA GRATISSIMA (AVOCADO) OIL .15 g/mL; HIPPOPHAE RHAMNOIDES SEED OIL .05 g/mL; CALENDULA OFFICINALIS FLOWER .01 g/mL
Marketing start2026-10-162026-10-22
Package configurations31
Launch Signal Score45/10015/100
Peer rank and all 500 records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: BRYTLY · BYT BANGYTONG STYE EYE RELIEF SERUM

Get new listings in your categories

FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.

See plans

Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.

Often used together